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ABSTRACT: Human plasma to be analyzed for exposure to
cholinesterase inhibitors is stored at 4 °C or lower to prevent
denaturation of human butyrylcholinesterase (HuBChE), the bio-
marker of exposure. Currently published protocols immunopurify
HuBChE using antibodies that bind native HuBChE before analysis by
mass spectrometry. It is anticipated that the plasma collected from
human casualties may be stored nonideally at elevated temperatures of
up to 45 °C for days or maybe weeks. At 45 °C, the plasma loses 50%
of its HuBChE activity in 8 days and 95% in 40 days. Our goal was to
identify a set of monoclonal antibodies that could be used to
immunopurify HuBChE from plasma stored at 45 °C. The folding
states of pure human HuBChE stored at 4 and 45 °C and boiled at 100
°C were visualized on nondenaturing gels stained with Coomassie
blue. Fully active pure HuBChE tetramers had a single band, but pure
HuBChE stored at 45 °C had four bands, representing native, partly unfolded, aggregated, and completely denatured, boiled
tetramers. The previously described monoclonal B2 18-5 captured native, partly unfolded, and aggregated HuBChE tetramers,
whereas a new monoclonal, C191 developed in our laboratory, was found to selectively capture completely denatured, boiled
HuBChE. The highest quantity of HuBChE protein was extracted from 45 °C heat-denatured human plasma when HuBChE was
immunopurified with a combination of monoclonals B2 18-5 and C191. Using a mixture of these two antibodies in future
emergency response assays may increase the capability to confirm exposure to cholinesterase inhibitors.
■ INTRODUCTION
The current Centers for Disease Control and Prevention
protocol for analyzing exposure to cholinesterase inhibitors is
based on the fact that organophosphorus toxicants bind
irreversibly to human butyrylcholinesterase (HuBChE) in
human plasma. Exposure is detected with mass spectrometry
by measuring an adduct on the active site serine of HuBChE in
the peptide FGESAGAAS.1−4 HuBChE is a minor component
in human plasma having a concentration of 4 mg/L against a
background protein concentration of 60 000 mg/L. The first
step in the published protocols selectively extracts HuBChE
from plasma by binding HuBChE to an immobilized
antiHuBChE monoclonal antibody.
It is anticipated that some plasma samples will have been
stored under conditions that denature HuBChE (i.e., at
elevated temperatures for prolonged periods). Monoclonals
that recognize denatured HuBChE would enhance the
sensitivity of the immunopurification-based assay for confirm-
ing exposure to cholinesterase inhibitors. Our goal was to
develop a set of monoclonals that could be used for
immunopurifying heat-inactivated, denatured HuBChE.
We started our study by asking what happens to pure
tetrameric HuBChE when it is stored at 4 and 45 °C and boiled
at 100 °C. We expected to find irreversible loss of activity in
HuBChE exposed to elevated temperatures, but we did not
know whether elevated temperatures caused the protein to
precipitate or the HuBChE tetramer to dissociate into dimers
and monomers or to fragment by breaking peptide bonds. We
also did not know which immobilized monoclonals would serve
to immunopurify heat-denatured HuBChE. Having learned
what to expect from our studies of pure HuBChE, we applied
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the information to human plasma samples stored at elevated
temperatures for prolonged times.
In this study, we use the term “boiled HuBChE” for heat-
denatured HuBChE. There are many ways to denature
HuBChE, including treatment with high or low temperatures,
organic solvents, high pressure,5 drying, aqueous solvents with
an extremely low or high pH, cross-linking agents such as
glutaraldehyde, chaotropic agents such as urea and guanidine
hydrochloride, digestion with proteases, disulfide bond-
reducing agents, and amino acid-modifying agents such as
fluorescent IRDye 800CW.6 Each of these can cause complete
loss of enzyme activity, so that the treated enzyme can be
described as “completely denatured”. However, the structural
change in the protein may be unique to the treatment.
Therefore, we define heat-denatured HuBChE as “boiled”
rather than as “completely denatured”.
■ MATERIALS AND METHODS
Materials. The following were from Millipore, Billerica,
MA: 0.22 μm presterilized disposable filtration system
(Stericup SCGVU11RE); Amicon Ultra-15 centrifugal filter
10 000 NMWL (UFC 901024); Durapore PVDF 0.45 μm
centrifugal filter (UFC30HV00). The following were from Bio-
Rad Laboratories Inc., Hercules, CA: Immun-Blot PVDF
membrane (162-0177); Clarity Western ECL substrate (170-
5060); Precast 4−20% gradient gels (456-1094); Mini-Protean
Tetra Cell (165-8003). Protein G agarose was from Protein
Mods LLC, Madison, WI, (product code PGGH). CNBr-
activated Sepharose 4B powder was from Amersham
Biosciences AB (GE Healthcare, Pittsburgh, PA, 17-0981-01).
Q-Ceramic HyperD F sorbent was from Pall Corp., Port
Washington, NY (cat# 20066-56). Hupresin is a new affinity gel
manufactured by Emilie David at Chemforase, Mont-Saint-
Aignan, France. 4−30% gradient gels, with a 4% stacking gel,
were poured in a vertical slab electrophoresis unit from Hoefer
Scientific Instruments, San Francisco, CA (SE 600). Frozen
Cohn fraction IV-4 was from Grifols Therapeutics Inc.,
Clayton, NC.
Antibodies. Monoclonal B2 18-5 was previously produced
against native HuBChE in mice.7 The heavy and light chain
nucleotides of B2 18-5 were sequenced, cloned into expression
vectors, expressed in a stable Chinese hamster ovary cell line,
and the antibody purified by Syd Labs, Natick, MA.8 B2 18-5
efficiently immunopurifies HuBChE from plasma stored at 4 or
−20 °C.8 Antimouse IgG conjugated to horse radish peroxidase
was from Cell Signaling, cat# 7076.
Monoclonal C191 was created at the University of Nebraska
Medical Center (UNMC) by injecting mice with denatured,
recombinant human HuBChE expressed in Chinese hamster
ovary cells. The recombinant HuBChE had been denatured and
reduced by boiling in 1% sodium dodecyl sulfate (SDS)
containing 5% mercaptoethanol before it was injected into mice
with an adjuvant. The coding sequence had been modified to
delete the 44 amino acids in the tetramerization domain at the
C-terminus and to reduce the number of N-glycans from nine
to five. The amino acid sequence and crystal structure of the
truncated HuBChE protein can be found in Protein Data Bank
entry 1P0I.9
Purification of Monoclonal C191 on Protein G
Agarose. Monoclonal C191 was purified from mouse
hybridoma cell culture medium on Protein G agarose using
0.1 M sodium phosphate pH 7.5 for equilibration and washing,
0.1 M citric acid pH 2.6 for elution, and 1 M sodium phosphate
pH 9.5 for neutralization. The buffer was changed to
phosphate-buffered saline (PBS), and the protein concentrated
to 5 mg/mL by diafiltration through an Amicon centrifugal
filter. Tris and azide were avoided because they interfere with
conjugation of antibody to CNBr-activated Sepharose.
Cross-linking Monoclonals C191 and B2 18-5 to CNBr-
Activated Sepharose. A 5 mg aliquot of each monoclonal in
buffer free of Tris and azide was cross-linked to 3.5 mL
Sepharose that had been swollen from 1 g of CNBr-activated
Sepharose 4B powder. The dry Sepharose was hydrated and
washed with 13 mL of ice-cold 1 mM HCl followed by 13 mL
of ice-cold coupling buffer, 0.15 M NaHCO3, 0.5 M NaCl pH
8. The beads were pelleted by centrifugation, and the liquid
discarded before addition of 5 mg monoclonal in 1 mL PBS and
1 mL coupling buffer. The tubes were rotated at room
temperature for 20 h. It was estimated that 99% of the antibody
bound to Sepharose as calculated from the observed
absorbance of 0.03 at 280 nm in the supernatant liquid. The
beads were washed twice with the coupling buffer, once with
Tris-buffered saline containing 0.2% Tween-20 and twice with
PBS 0.05% sodium azide. The 3.5 mL beads coupled to 5 mg
monoclonal were stored in a total volume of 15 mL PBS 0.05%
azide at 4 °C. A 0.1 mL suspension has 33 μg monoclonal
bound to 23 μL beads.
Pure HuBChE. Cohn fraction IV-4, a byproduct of the
human plasma fractionation industry, was the starting material
for purifying large quantities of HuBChE.10,11 HuBChE was
purified from frozen Cohn fraction IV-4 paste using anion-
exchange chromatography on Q-Ceramic HyperD F sorbent
followed by affinity chromatography on hupresin. Hupresin was
recently introduced as a new affinity gel for purification of
rHuBChE expressed in insect cells.12
Human Plasma. Pooled human plasma from the Nebraska
Medical Center Blood Bank contained acid citrate dextrose
anticoagulant.
Heat Inactivation of Pure Human HuBChE. Pure
plasma-derived HuBChE was diluted with PBS 0.1% azide to
an activity of 27.5 u/mL and a protein concentration of 0.05
mg/mL. 1 mL aliquots of HuBChE were stored at 4, 24, 37,
and 45 °C. The 100 °C sample was prepared by heating a 1 mL
aliquot in a boiling water bath for 5 min, a procedure that
completely destroyed HuBChE activity with butyrylthiocholine.
The boiled HuBChE was stored at 4 °C. The stability of
HuBChE activity was measured as a function of time of storage
in Figure 1.
Inactivation of HuBChE in Human Plasma at 45 °C.
Human plasma was incubated at 45 °C (113 °F). The loss of
HuBChE activity in plasma was measured as a function of time
at 45 °C.
HuBChE Activity. Activity was measured with 1 mM
butyrylthiocholine iodide in 0.1 M potassium phosphate pH 7.0
containing 0.5 mM 5,5′-dithiobis(2-nitrobenzoic acid) at 25 °C
by recording the increase in absorbance at 412 nm on a Gilford
spectrophotometer interfaced to MacLab (ADInstruments,
Colorado Springs, CO). The increase in absorbance between
10 and 40 s was used to calculate units per milliliter where a
unit (u) of activity is micromoles hydrolyzed per minute. The
extinction coefficient for the calculation was 13.6 mM−1 cm−1.13
Gel Shift Assay. The complex formed between monoclonal
B2 18-5 and heat-inactivated pure HuBChE was visualized on a
nondenaturing 4−30% gradient polyacrylamide gel, overlaid
with a 4% stacking gel, and stained with Coomassie blue. The
samples were prepared for nondenaturing gel electrophoresis
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by incubating 10 μL of pure HuBChE (0.48 mg/mL) with
either 5 or 2 μL of monoclonal B2 18-5 (0.91 mg/mL) adjusted
to 15 μL with PBS, at room temperature for 2 h. A 15 μL
aliquot of 60% glycerol, 0.1% bromphenol blue was added to
each tube before the samples were loaded on a nondenaturing
gel. Electrophoresis at 300 V (constant voltage) was conducted
for 24 h at 4 °C in a Hoefer gel apparatus. The gel shift assay is
shown in Figure 3.
Activity Stained Gel. A nondenaturing 4−30% gradient gel
was stained for HuBChE activity by the method of Karnovsky
and Roots,14 as shown in Figure 4.
Capture of Heat-Inactivated Pure HuBChE by Immo-
bilized Monoclonals. The selective removal of partly
unfolded HuBChE by immobilized B2 18-5 and of completely
denatured HuBChE by immobilized C191 was visualized on a
nondenaturing 4−30% gradient gel stained with Coomassie
blue. The Sepharose beads in 0.3 mL suspension of
immobilized B2 18-5 or C191 occupied a volume of 70 μL
after the liquid phase was discarded. Pure HuBChE in PBS
0.1% azide at a concentration of 0.48 mg/mL had been stored
at 4 or 45 °C or boiled in a 100 °C water bath and then stored
at 4 °C. A 30 μL aliquot of pure HuBChE was added to the
beads and mixed in a rotating mixer for 5 h at room
temperature. A 10 μL aliquot of the clear supernatant was
removed from each incubation mixture for gel electrophoresis
on a nondenaturing gradient gel stained with Coomassie blue
to visualize bands not captured by the monoclonals. The
method was used in Figure 6.
The beads were washed with detergent-containing buffer
(PBS with 1% Triton X-100, 0.5% sodium deoxycholate, 0.1%
SDS, 20 mM ethylenediaminetetraacetic acid (EDTA), 10 mM
sodium azide, HCl adjusted to pH 6.5), and the bound protein
was released with 50% acetonitrile 1% trifluoroacetyl (TFA).
The method was used for the SDS gel in Figure 7.
Dynamic Light Scattering. The size of the pure HuBChE
samples stored at 4, 45 °C or boiled at 100 °C was measured on
the Zetasizer Nano ZS instrument (Malvern Instruments Ltd.,
Malvern, UK) in disposable folded capillary cells (DTS1070)
for 0.1 mL aliquots of 0.5 mg/mL of HuBChE in PBS.
Measurements at 25 °C were repeated three times for a total of
42 scans per sample.
Capture of Heat-Inactivated HuBChE from Human
Plasma Stored at 45 °C. Human plasma (1 mL) stored at 45
°C for 14 days lost 60% of its original HuBChE activity and
developed a heavy precipitate. The liquid and solid phases were
treated separately. The 0.85 mL plasma in the liquid phase was
clarified through a 0.45 μm nylon syringe filter before a 0.7 mL
aliquot of the filtered plasma was incubated with a mixture of
0.2 mL immobilized B2 18-5 and 0.2 mL immobilized C191. It
was estimated that each 0.2 mL suspension contained 66 μg
monoclonals conjugated to 46 μL beads. The samples were
rotated at room temperature overnight. The beads were
transferred to a 0.45 μm centrifugal filter where they were
washed three times with PBS containing 0.05% Tween-20 and
two times with water.
HuBChE in the 45 °C plasma pellet was partly solubilized
with 400 μL of 1% Triton X-100 in PBS at 37 °C overnight.
The supernatant was diluted 10-fold with PBS before addition
of 0.2 mL immobilized B2 18-5 and 0.2 mL immobilized C191
suspensions. The samples were mixed overnight at room
temperature and washed as above in preparation for Western
blotting.
Western Blot. HuBChE immunopurified from human
plasma was visualized on Western blots in Figure 8. Proteins
were extracted from immobilized B2 18-5 and C191
monoclonals with 200 μL of 50% acetonitrile 0.1% trifluoro-
acetic acid. The extract was dried, suspended in 5 μL water and
5 μL Laemmli buffer (0.125 M TrisCl, 4% SDS, 20% glycerol,
10% 2-mercaptoethanol at pH 6.8, 0.01% bromophenol blue),
heated in a boiling water bath for 3 min, and loaded on an 8%
SDS polyacrylamide gel. Following electrophoresis, proteins
were transferred to a PVDF membrane in 25 mM Tris, 192
mM glycine pH 8.3 at 4 °C for 1 h at 350 mA. The membrane
was blocked in 5% nonfat dry milk in 50 mM Tris pH 7.4, 150
mM NaCl, 0.02% Tween-20 (TBST with 5% milk) for 1 h,
followed by washing three times with TBST. The blot was
incubated at 4 °C overnight with 20 μL monoclonal antibody
C191 culture medium diluted in 10 mL PBS containing 5%
milk. The membrane was washed three times with TBST and
incubated 1 h at room temperature with 1 μL antimouse IgG
linked to horse radish peroxidase in 5 mL of TBST containing
5% milk. The membrane was washed with TBST. Bands were
visualized by treating the blot with Clarity Western ECL
substrate and detecting the emitted light on X-ray film. Known
quantities of pure HuBChE were loaded on the SDS gel to
serve as controls.
LC-MS/MS on the 6600 Triple-TOF Mass Spectrometer
(AB Sciex). Mass spectrometry was used to demonstrate that
monoclonal C191 recognizes denatured HuBChE immuno-
purified from 45 °C heat-treated plasma. Following incubation
with plasma, the beads were transferred to a 0.45 μm centrifugal
filter where they were washed with a detergent-containing
buffer (1% Triton X-100, 0.5% sodium deoxycholate, 0.1%
SDS, 20 mM EDTA, and 10 mM NaN3 in PBS adjusted to pH
6.5) and desalted by washing with water. Proteins captured by
immobilized monoclonal C191 were released with 100 μL of
50% acetonitrile 0.1% TFA, dried, dissolved in 20 mM
ammonium bicarbonate, and digested with trypsin. A 5 μL
aliquot of the digest was analyzed using liquid chromatography
Figure 1. Stability of pure HuBChE in PBS 10 mM azide. Pure
HuBChE with an activity at time zero of 27.5 units/mL and a protein
concentration of 0.055 mg/mL was incubated in 1 mL aliquots at
various temperatures. HuBChE activity was monitored for 43 days.
Triplicate assays were performed at each time point.
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(LC)−mass spectrometry (MS)/MS. Details of the LC-MS/
MS system have been previously described.15
Amino Acid Sequence of Monoclonals C191 and B2
18-5. The nucleotide and deduced amino acid sequences of the
light and heavy chains of monoclonals C191 and B2 18-5 were
determined by Syd Labs (Natick, MA) from the mRNA in
hybridoma cells. The reported sequences were validated by
testing the specificity of the recombinant monoclonals
produced by transient expression in mammalian cells.
■ RESULTS
Stability of Pure HuBChE in PBS at Various Temper-
atures. The goal was to identify a temperature and storage
time that converts HuBChE to the type of unfolded, inactive
molecule present in plasma that has been stored at elevated
temperatures. Figure 1 shows that solutions of pure HuBChE at
a concentration of 0.05 mg/mL were stable at 4 and 24 °C for
at least 43 days. Storage at 37 °C resulted in a slow loss of
HuBChE activity with time; the activity after 14 days at 37 °C
was 87% and after 43 days was 70% of the initial activity.
Storage at 45 °C resulted in a loss of 50% of the HuBChE
activity in 2.5 days and 95% loss in 14 days. Pure HuBChE that
had been denatured in a boiling water bath (100 °C) had no
activity following heat treatment.
Plasma Stored at Elevated Temperatures. Human
plasma in anticoagulant citrate dextrose lost HuBChE activity
when the plasma was incubated at the elevated temperature of
45 °C (113 °F). Figure 2 shows that after 8 days at 45 °C, the
HuBChE activity in plasma was 50% of its initial activity. After
19 days at 45 °C, the plasma lost 75% of its initial activity, and
after 39 days, it lost 93% of its initial HuBChE activity.
After a chemical emergency, researchers may be required to
analyze plasma samples that have been stored at temperatures
as high as 45 °C. The methods published to date use HuBChE
in plasma samples that are stored frozen or refrigerated. The
loss of HuBChE activity in samples stored at 45 °C suggests the
HuBChE protein has undergone unfolding and that the
unfolded HuBChE protein may require the use of an antibody
directed to denatured HuBChE.
Folding States of HuBChE. Antibody binding and gel
electrophoresis experiments described below showed that pure
HuBChE incubated at 45 °C contains inactive HuBChE
structures in addition to fully active, native HuBChE. A partly
unfolded HuBChE structure and an aggregated HuBChE
structure are recognized by monoclonal B2 18-5, the same
monoclonal that captures native HuBChE. The completely
denatured HuBChE is recognized by monoclonal C191. Table
1 presents the monoclonals that distinguish the folding states of
heat-inactivated HuBChE and the methods to produce these
folding states. Table 1 does not include plasma heated to 100
°C because plasma congeals to a solid form at 100 °C, a
condition not amenable to antibody-binding assays.
Gel Shift Assay. The gel shift assay in Figure 3
demonstrates that storage of pure HuBChE in PBS azide at
45 °C for 9 days with 55% loss of activity creates HuBChE
structures that differ from native and boiled HuBChE. The
nondenaturing gel compares the migration of pure HuBChE
stored at 4 °C (lane 1), 45 °C (lane 2), and 100 °C (lane 3).
The HuBChE tetramer stored at 4 °C has a single band (lane
1), whereas the 45 °C heat-inactivated HuBChE (lane 2) has
bands for native and partly unfolded, a faint band
corresponding to boiled HuBChE, and a diffuse band near
the top of the gel for aggregated HuBChE. The boiled
HuBChE (lane 3) has an intense band that migrates further
toward the positive pole than the native HuBChE tetramer, and
in addition has diffuse aggregated bands near the top of the gel
and a faint band slightly above the native tetramer band. The
fastest migrating band in lane 2 (which is barely detectable in
lane 2 but visible in lane 6) is at the position of boiled HuBChE
in lane 3, suggesting that some of the 45 °C heat-inactivated
HuBChE is completely denatured.
Figure 3 lane 5 shows that 4.5 μg of monoclonal B2 18-5
shifts the migration of 4.4 μg native HuBChE to slower moving
bands near the top of the gel. This ratio of monoclonal to
HuBChE protein captures all the HuBChE. The IgG
monoclonal has two antigen-binding domains per molecule.
The HuBChE tetramer has four antibody binding sites per
tetramer, enabling it to form a polymer-like complex that cross-
links several HuBChE tetramers through interaction with two
or more monoclonals. The bands at the top of lanes 5, 6, 8, and
9 probably represent such high molecular weight complexes.
When the HuBChE (4.4 μg) concentration exceeds the
antibody concentration (1.8 μg) as in lane 8, the cross-linking
may be minimized to yield lower molecular weight complexes
where one HuBChE tetramer binds only one or two antibodies.
The two bands in lane 8 that are missing from lane 5 may
represent one HuBChE tetramer bound to one or two
antibodies.
Figure 2. Loss of HuBChE activity in human plasma stored at 45 °C.
Values for triplicate assays are too close to show up in error bars.
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Figure 3 lane 6 shows that 4.5 μg of monoclonal B2 18-5
shifts the migration of bands corresponding to native and partly
unfolded tetramers in 45 °C heat-inactivated HuBChE, but
does not shift the band that corresponds to boiled HuBChE.
Lane 7 confirms that B2 18-5 does not recognize completely
denatured HuBChE. We conclude that native, partly unfolded,
and aggregated HuBChE structures bind to B2 18-5. However,
completely denatured HuBChE does not bind to B2 18-5.
The gel in Figure 3 has a stacking gel on top of a 4−30%
acrylamide gradient. Electrophoresis was performed for 24 h at
300 V constant voltage in a Hoefer apparatus. This system
separated the unbound antibody (lane 4) from unbound
Figure 3. Gel shift assay on a nondenaturing 4−30% gradient gel with 4% stacking gel, stained with Coomassie blue. (1) Pure HuBChE tetramer
stored at 4 °C has a single band. (2) Pure HuBChE stored at 45 °C has a band for native HuBChE, a faster migrating band for unfolded HuBChE, a
barely detectable band at the level of boiled HuBChE, and a diffuse slow-moving band for aggregated forms. (3) Boiled pure HuBChE has a
prominent band that migrates faster than the unfolded band in lane 2; in addition boiled HuBChE has several diffuse aggregated bands. (4)
Monoclonal B2 18-5 migrates faster toward the positive pole than HuBChE. (5) Monoclonal B2 18-5 forms a complex with native 4 °C HuBChE
seen as prominent bands near the top of the gel; lane 5 shows no unbound HuBChE. (6) B2 18-5 forms a complex with native and partially unfolded
HuBChE in the 45 °C sample but does not form a complex with boiled HuBChE. (7) B2 18-5 does not bind any of the protein forms in boiled
HuBChE. (8) 1.8 μg monoclonal B2 18-5 is saturated by 4.4 μg native HuBChE, forming additional complexes compared to those in lane 5. (9) 1.8
μg antibody captured all of the native, partially unfolded, and aggregated HuBChE in the 45 °C sample but not the structure representing boiled
HuBChE. (10) 1.8 μg antibody did not capture boiled HuBChE. The direction of migration was toward the positive pole, indicated by the + sign.
Figure 4. Low HuBChE activity in unfolded HuBChE. The nondenaturing gradient gel in panel A stained with Coomassie blue was loaded with 4.4
μg HuBChE protein per lane. The gel in panel B stained for HuBChE activity was loaded with 0.005 units of HuBChE activity, which required 0.01
μg of HuBChE protein for the 4 °C sample and 0.04 μg HuBChE protein for the 45 °C sample. The 100 °C sample had no activity.
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HuBChE tetramers (lane 1). However, when the same samples
were run on a precast 4−20% gradient gel (no stacking gel), the
unbound HuBChE migrated to the same position as the
unbound antibody.
Low Activity in the Partly Unfolded HuBChE. The
epitope for binding monoclonal B2 18-5 was present in native,
partly unfolded HuBChE and in aggregated HuBChE produced
at 45 °C but was absent in completely denatured HuBChE.
This means that the epitope is formed by a three-dimensional
arrangement of residues, rather than by adjacent residues in a
linear segment. To determine which folding states of HuBChE
have HuBChE activity, the samples were subjected to
nondenaturing gel electrophoresis in Figure 4B, where the gel
was stained for HuBChE activity. For comparison, the gel in
Figure 4A was stained with Coomassie blue to show the
location of HuBChE bands in pure HuBChE stored at 4, 45 °C
and boiled at 100 °C. Lanes 4 and 5 in Figure 4B show an
intense band of activity for the native HuBChE tetramer. The
45 °C sample in lane 5 has faint bands of activity for the
unfolded and aggregated HuBChE. The boiled HuBChE
sample in lane 6 had no activity. It was concluded that the
partly unfolded HuBChE and aggregated HuBChE structures
produced by storage at 45 °C have a very low level of HuBChE
activity. Furthermore, the aggregated forms that have HuBChE
activity in the sample stored at 45 °C have a different structure
than the aggregated forms in boiled HuBChE that have no
HuBChE activity.
HuBChE Aggregates to 30 times Normal Size. The size
of pure HuBChE stored at elevated temperatures was estimated
by dynamic light scattering (DLS). The mean diameter of the
340 kDa HuBChE tetramer was 20 nm for HuBChE stored at 4
°C (see Figure 5), 18 nm for HuBChE stored at 45 °C, and 17
nm for boiled HuBChE. The broad peak for pure HuBChE is
attributed to microheterogeneity of the 36 asparagine-linked
glycans in the 340 kDa tetramer. The storage of pure HuBChE
in PBS azide for 9 days at 45 °C converted 20% of the HuBChE
to aggregates with a diameter of 490 nm. Boiling converted 5%
of HuBChE to aggregates with a diameter of 100 nm and 45%
of HuBChE to aggregates with a mean diameter of 620 nm.
DLS did not resolve HuBChE into the bands visualized by
nondenaturing gel electrophoresis. For example, the most
intense band in boiled HuBChE (Figure 3, lane 3) migrates
further than the band in 4 °C HuBChE (Figure 3, lane 1). This
difference is not apparent in Figure 5. Coomassie blue staining
of the nondenaturing gel in Figure 3 showed only faint bands
for aggregated HuBChE in the 100 °C sample, whereas DLS
indicated that 50% of the HuBChE had aggregated. Both
methods agree that heating under our conditions produces high
molecular weight aggregates, but does not fragment the
HuBChE protein into smaller peptides.
Nondenaturing Gel Shows HuBChE Bands Not
Captured by B2 18-5 and C191. A second approach for
demonstrating the specificity of monoclonals B2 18-5 and C191
used nondenaturing gel electrophoresis to show the bands of
pure HuBChE that failed to bind to immobilized antibodies. In
Figure 6, lane 4 is blank, which means all the native 4 °C pure
HuBChE was captured by B2 18-5. In lane 5 for 45 °C heat-
inactivated HuBChE, all bands disappeared (compare lanes 2
and 5), except for a faint band at the position of boiled
HuBChE. This means only native HuBChE, partly unfolded,
and aggregated HuBChE are recognized by B2 18-5. The bands
for boiled HuBChE are present in lane 6, indicating that B2 18-
5 does not recognize completely denatured HuBChE. By
contrast, lane 9 is nearly blank, which shows that C191
captured boiled HuBChE. However, C191 did not bind native
HuBChE (lane 7) and did not bind the bands in 45 °C
HuBChE for native and partly unfolded HuBChE (lane 8). The
nondenaturing gel in Figure 6 shows that 33 μg immobilized B2
18-5 captured 100% of the 5 μg of native, partially unfolded,
and aggregated HuBChE in 4 and 45 °C samples, whereas 33
μg immobilized C191 captured 99% of the 5 μg boiled
HuBChE. In a previous study,8 we have shown that 20 μg
immobilized monoclonal B2 18-5 captures 97% of the HuBChE
in 0.5 mL human plasma. We expect that B2 18-5 and C191
monoclonals used together will immunopurify the maximum
amount of HuBChE from human plasma stored at elevated
temperatures.
SDS Gel Confirms the Capture of Native, Partly
Unfolded, and Aggregated HuBChE by B2 18-5 and
the Capture of Completely Unfolded HuBChE by C191.
Pure HuBChE at a concentration of 0.48 mg/mL in PBS azide
lost no activity at 4 °C, lost 60% activity in 15 days at 45 °C,
and lost 100% activity in a boiling water bath. The heat-treated
pure HuBChE remained in solution and did not precipitate.
Immobilized monoclonals B2 18-5 and C191 (100 μg
monoclonal bound to 70 μL Sepharose beads) were incubated
with 13 μg of pure HuBChE in 30 μL PBS for 5 h at room
temperature. The beads were washed with detergent-containing
buffer, and the bound protein was released with 50%
acetonitrile 1% TFA. Bound HuBChE released from the
immobilized monoclonals is visualized in Figure 7. The SDS gel
shows that HuBChE heated to 45 or 100 °C has the same
monomer molecular weight of 85 kDa and dimer of 170 kDa as
HuBChE stored at 4 °C. Thus, heat treatment did not break
peptide bonds. HuBChE (lane 1) stored at 4 °C has a band at
85 kDa, indicating that native HuBChE was bound by
monoclonal B2 18-5. However, there is no HuBChE band in
lane 4, indicating that monoclonal C191 did not bind native
HuBChE. The bands for HuBChE are present in lanes 2 and 5,
indicating that HuBChE stored at 45 °C contains HuBChE
Figure 5. DLS of pure HuBChE stored at 4 and 45 °C and boiled at
100 °C. The 4 °C sample consists predominantly of 340 kDa HuBChE
tetramers with an average diameter of 20 nm. Heat treatment produces
aggregates with an average diameter of 500−600 nm.
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folding states captured by both B2 18-5 and C191 monoclonals.
There is no HuBChE band in lane 3, indicating that the boiled
HuBChE is not recognized by B2 18-5. However, there is a
HuBChE band in lane 6, indicating that monoclonal C191
binds denatured HuBChE. These results confirm the binding
specificity of B2 18-5 for native, partly unfolded, and aggregated
HuBChE, whereas C191 specifically binds completely dena-
tured HuBChE. All folding statesnative, partly unfolded,
aggregates, and completely unfoldedare present in HuBChE
stored at 45 °C. The use of both antibodies together is expected
to yield the highest amount of immunopurified HuBChE.
Monoclonals B2 18-5 and C191 Immunopurify
HuBChE from 45 °C Heat-Inactivated Plasma. Having
established that heat-denatured pure HuBChE remains in
solution, and that B2 18-5 and C191 immunopurify heat-
denatured pure HuBChE, we tested these monoclonals for their
ability to immunopurify HuBChE from human plasma stored at
45 °C. Western blotting was used to detect HuBChE
immunopurified from plasma. Immobilized monoclonals B2
18-5 and C191 were incubated with control plasma stored at 4
°C or with the supernatant in 45 °C heat-inactivated plasma.
The plasma stored at 45 °C developed a heavy precipitate. The
4 °C control plasma contained no pellet. The possibility was
tested that HuBChE was trapped in the plasma precipitate. The
pellet was extracted with Triton X-100, and the diluted extract
was incubated with immobilized B2 18-5 and C191. The
Western blot in Figure 8A for control plasma (lane 4) indicates
a recovery of about 0.5 μg HuBChE from 1 mL control plasma
stored at 4 °C. HuBChE activity in the control plasma was 1.8
u/mL, which corresponds to 2.5 μg of HuBChE protein. A
recovery of 20% HuBChE protein is therefore expected from
heat-inactivated plasma processed through the immunopur-
ification and Western blotting steps.
The Western blot in Figure 8B shows HuBChE immuno-
purified from plasma stored at 45 °C for 3 weeks. After 1 mL
plasma had been separated from the pellet and filtered, only 0.7
mL of plasma remained for incubation with immobilized
antibodies. The band intensities in lane 8 correspond to a
recovery of about 0.2 μg of HuBChE protein from 0.7 mL
plasma, a percent recovery similar to that for control plasma in
Figure 6. Nondenaturing gel electrophoresis stained with Coomassie blue. Pure HuBChE stored at 4 and 45 °C or boiled was incubated with
immobilized B2 18-5 or with immobilized C191. Unbound protein was loaded on the gel. Lanes 1−3 were loaded with 5 μg pure HuBChE. Lanes
4−9 show the unbound HuBChE remaining in solution after incubation of 5 μg HuBChE with 33 μg immobilized monoclonal.
Figure 7. HuBChE captured by immobilized monoclonals was
released from binding and visualized on an SDS gel stained with
Coomassie blue. HuBChE stored at 4 °C was captured by B2 18-5
(lane 1) but not by C191 (lane 4). HuBChE stored at 45 °C was
captured by B2 18-5 (lane 2) and C191 (lane 5). Boiled HuBChE was
not captured by B2 18-5 (lane 3) but was captured by C191 (lane 6).
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lane 4. Comparison of band intensities for HuBChE
immunopurified from the plasma supernatant (lane 8) and
the pellet (lane 9) shows that the supernatant contained most
of the HuBChE protein. This result for plasma is consistent
with the observation that pure HuBChE remained in solution
after prolonged incubation at 45 °C and after denaturation in a
boiling water bath.
Plasma stored at 45 °C for 2 weeks with a 67% loss of
HuBChE activity was immunopurified with immobilized B2 18-
5. The extracted protein gave a good HuBChE signal on a
Western blot, corresponding to about 0.2 μg of protein. The
same sample immunopurified with C191 gave a weak signal,
corresponding to 0.02 μg of HuBChE. After 3 weeks at 45 °C,
when plasma had lost 80% of its HuBChE activity, the two
monoclonals captured equal amounts of HuBChE proteins.
Mass Spectrometry Confirms that C191 Immunopuri-
fies HuBChE from Heat-Denatured Plasma. Human
plasma stored at 45 °C for 3 weeks with 80% loss of HuBChE
activity was incubated with immobilized C191 monoclonal.
Protein released from the washed beads was digested with
trypsin and analyzed by LC-MS/MS on a 6600 Triple-TOF
mass spectrometer. Protein Pilot software identified the
HuBChE peptides colored green and red in Figure 9. Of the
574 amino acids in the mature HuBChE protein, 217 amino
acids were identified in Figure 9 for a coverage of 38%. Mass
spectrometry confirmed the finding from Western blots that
monoclonal C191 immunopurifies HuBChE from heat-
inactivated plasma. This means that some of the HuBChE in
plasma stored at 45 °C is completely denatured.
Amino Acid Sequences of Monoclonals B2 18-5 and
C191. The amino acid sequences of monoclonals B2 18-5 and
C191 in Figure 10 were deduced from the nucleotide sequences
of the cDNA. The complementarity-determining regions
(CDRs) are boxed because they are the hypervariable domains
that determine antibody-binding specificity.
The nucleotide and amino acid sequences for monoclonals
B2 18-58 and C191 have been deposited in the National Center
for Biotechnology Information database under the accession
numbers listed in Table 2. Knowledge of the sequences of
monoclonals is valuable because it allows one to produce the
monoclonals using recombinant DNA techniques when the
hybridoma cells are unavailable or when the antibody genes in
the hybridoma cells have undergone deleterious mutations.
■ DISCUSSION
Antibodies for Immunopurification of Heat-Inacti-
vated HuBChE from Plasma. Monoclonals B2 18-5 and
C191 can be used to immunopurify heat-inactivated HuBChE
in human plasma that has been stored at 45 °C. Monoclonal B2
18-5 recognizes native HuBChE and two HuBChE con-
Figure 8. (A) Western blot for HuBChE immunopurified from 1 mL
control 4 °C plasma (lane 4) by an equal mixture of immobilized B2
18-5 and C191 indicates a recovery of 20% HuBChE protein, which is
based on the comparison to the pure HuBChE standards in lanes 1−3.
(B) Western blot for HuBChE immunopurified from 45 °C heat-
inactivated plasma by a 1:1 mixture of immobilized B2 18-5 and C191.
More HuBChE was recovered from the supernatant (lane 8) than the
pellet (lane 9).
Figure 9. Mass spectrometry analysis of denatured HuBChE captured by monoclonal C191 from plasma stored at 45 °C for 3 weeks. Peptides
identified with 99% confidence are colored green, with 50% confidence are colored red. The accession number for HuBChE is P06276.
Figure 10. Amino acid sequences of the light and heavy chain variable
regions of mouse anti-HuBChE monoclonal antibodies B2 18-5,
isotype IgG2b κ, and C191, IgG1 κ. The CDRs were defined using
VBASE2 http://www.vbase2.org/.
Table 2. Accession Numbers for Monoclonals B2 18-5 and
C191
mouse monoclonal isotype NCBI accession number
B2 18-5 heavy chain IgG2b KT189143
B2 18-5 light chain κ KT189144
C191 heavy chain IgG1 KX278822
C191 light chain κ KX278823
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formations that have minimal activity. Monoclonal C191
recognizes a completely denatured HuBChE structure. The
use of these antibodies in combination is expected to capture
95% of HuBChE from plasma stored at elevated temperatures,
making it possible to determine nerve agent exposure in plasma
stored under nonideal conditions.
Other monoclonal antibodies to HuBChE can be used in
place of B2 18-5 to capture HuBChE from plasma. Monoclonal
HAH 002-01, also called 3E8, from BioPorto Diagnostics or
from Thermo Fisher has been used by the Centers for Control
and Prevention (Atlanta, GA) and the Federal Medical-
Biological Agency of Russia (St. Petersburg) to immunopurify
HuBChE from plasma.1,16 Monoclonal 3E8 has been used in a
magnetic electrochemical sensing platform to monitor exposure
to organophosphorus agents.17
Monoclonals mAb2 and B2 12-1 can also be used to
immunopurify HuBChE from plasma,8 although they are not
commercially available. These antibodies can be made by
recombinant DNA methods using the nucleotide and amino
acid sequences we have deposited in the NCBI database.8
Monoclonals C191 and 11D88,18 are the only monoclonals
that recognize heat-denatured HuBChE. Monoclonal C191 was
made against a boiled and reduced truncated HuBChE
monomer called L530stop that was missing 44 amino acids
from the C-terminal tetramerization domain. The epitope for
binding C191 is available not just in denatured monomeric
HuBChE but also in heat-denatured tetrameric and aggregated
HuBChE. Both C191 and 11D8 can be used in Western blots
and ELISA. Immunohistochemical analysis of HuBChE in
tissue sections fixed with paraformaldehyde has been successful
with monoclonal 11D818 but has not been studied with C191.
The monoclonals listed above were created in mice and do
not recognize mouse BChE. However, Mrvova et al.19 created
monoclonals that specifically recognize mouse BChE by
immunizing BChE knockout mice with mouse BChE.
Monoclonals B2 18-5 and mAb2 have broad species specificity,
recognizing BChE in plasma of human, monkey, horse, cat,
tiger, and rabbit.20
HuBChE Has Conformations Distinguishable by
Monoclonal Antibodies. Native HuBChE with normal
HuBChE activity is recognized by monoclonal B2 18-5.
HuBChE protein with little residual activity due to heat-
inactivation at 45 °C is also recognized by monoclonal B2 18-5.
This monoclonal does not recognize completely misfolded
HuBChE produced by heating a HuBChE solution in a boiling
water bath. The selectivity of monoclonal B2 18-5 for
minimally active HuBChE conformations that are different
from the conformations of boiled HuBChE demonstrates the
existence of several misfolded states of HuBChE.
Additional evidence for more than one misfolded HuBChE
structure comes from a study that used urea-gradient
polyacrylamide electrophoresis to show that tetrameric
HuBChE unfolds via several partially unfolded states.21
Folding and Aggregation States of HuBChE. Native
HuBChE in human plasma is a tetramer of four identical
subunits. Each subunit contains 574 amino acids, 3 intrachain
disulfide bonds, 1 interchain disulfide bond, and 9 asparagine-
linked glycans. The tetramer is a dimer of dimers formed by an
interchain disulfide bond at Cys 571.22 HuBChE assembles into
a tetramer via contact with polyproline-rich peptides derived
from lamellipodin.23−25 The polyproline-rich peptides interact
with the tryptophan-rich C-terminus of HuBChE.26
Pure HuBChE heated to 100 °C releases its polyproline
peptides.23−25 We had expected the boiled HuBChE to
dissociate to dimers. However, the DLS experiment and the
nondenaturing gel had no hints of a HuBChE dimer. It seems
the subunits reassembled into tetramers and high molecular
weight aggregates by forming new disulfide bonds and by
associating via hydrophobic interactions. Heat-treated pure
HuBChE has been shown by others to contain high molecular
weight aggregates that separate from the 340 kDa HuBChE
tetramer on a size-exclusion chromatography column.27
Heating pure HuBChE in PBS to 100 °C for 5 min or 45 °C
for 9 days did not break peptide bonds.
The molten globule states of the HuBChE tetramer have
been studied by subjecting HuBChE to hydrostatic pressure.5 A
pressure of 2 kbar irreversibly inactivated HuBChE without
significantly changing its secondary structure. A pressure of 8
kbar completely unfolded the HuBChE tetramer but did not
dissociate the tetramer. Upon release of pressure, the HuBChE
protein formed aggregates with no catalytic activity. Thus,
denaturation by high pressure and denaturation by high
temperature yield similar misfolded HuBChE structures.
Method to Detect Inactive HuBChE in Pure HuBChE
Preparations. The present study demonstrates a method for
detecting inactive HuBChE in a pure human HuBChE
preparation. A preparation free of inactive HuBChE has a
single band on a nondenaturing polyacrylamide gel stained with
Coomassie blue. However, a preparation containing a
significant proportion of partly denatured HuBChE has
multiple bands on a nondenaturing gel and a lower than
expected activity per milligram protein. These additional bands
could be interpreted as originating from contaminating
proteins, when in fact they simply represent inactive HuBChE
structures. Pure HuBChE intended for clinical trials in humans
could be tested for the presence of aggregated HuBChE by
nondenaturing gel electrophoresis.
■ DISCLAIMER
The findings and conclusions in this article are those of the
authors and do not necessarily represent the views of the
Centers for Disease Control and Prevention. The use of trade
names is only for identification and does not imply endorse-
ment by the Centers for Disease Control and Prevention, the
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(5) Masson, P.; Cleŕy, C. Pressure-induced molten globule states of
proteins. High Pressure Bioscience and Biotechnology; Hayashi, R., Balny,
C., Eds.; Elsevier Science, 1996; pp 117−126.
(6) Gaydess, A.; Duysen, E.; Li, Y.; Gilman, V.; Kabanov, A.;
Lockridge, O.; Bronich, T. Visualization of exogenous delivery of
nanoformulated butyrylcholinesterase to the central nervous system.
Chem.−Biol. Interact. 2010, 187, 295−298.
(7) Brimijoin, S.; Mintz, K. P.; Alley, M. C. Production and
characterization of separate monoclonal antibodies to human
acetylcholinesterase and butyrylcholinesterase. Mol. Pharmacol. 1983,
24, 513−520.
(8) Peng, H.; Brimijoin, S.; Hrabovska, A.; Targosova, K.; Krejci, E.;
Blake, T. A.; Johnson, R. C.; Masson, P.; Lockridge, O. Comparison of
5 monoclonal antibodies for immunopurification of human butyr-
ylcholinesterase on Dynabeads: KD values, binding pairs, and amino
acid sequences. Chem.−Biol. Interact. 2015, 240, 336−345.
(9) Nicolet, Y.; Lockridge, O.; Masson, P.; Fontecilla-Camps, J. C.;
Nachon, F. Crystal structure of human butyrylcholinesterase and of its
complexes with substrate and products. J. Biol. Chem. 2003, 278,
41141−41147.
(10) Saxena, A.; Tipparaju, P.; Luo, C.; Doctor, B. P. Pilot-scale
production of human serum butyrylcholinesterase suitable for use as a
bioscavenger against nerve agent toxicity. Process Biochem. 2010, 45,
1313−1318.
(11) Lynch, T. J.; Mattes, C. E.; Singh, A.; Bradley, R. M.; Brady, R.
O.; Dretchen, K. L. Cocaine detoxification by human plasma
butyrylcholinesterase. Toxicol. Appl. Pharmacol. 1997, 145, 363−371.
(12) Brazzolotto, X.; Wandhammer, M.; Ronco, C.; Trovaslet, M.;
Jean, L.; Lockridge, O.; Renard, P.-Y.; Nachon, F. Human
butyrylcholinesterase produced in insect cells: Huprine-based affinity
purification and crystal structure. FEBS J. 2012, 279, 2905−2916.
(13) Ellman, G. L.; Courtney, K. D.; Andres, V., Jr.; Featherstone, R.
M. A new and rapid colorimetric determination of acetylcholinesterase
activity. Biochem. Pharmacol. 1961, 7, 88−95.
(14) Karnovsky, M. J.; Roots, L. A “direct-coloring” thiocholine
method for cholinesterases. J. Histochem. Cytochem. 1964, 12, 219−
221.
(15) Schopfer, L. M.; Lockridge, O.; Brimijoin, S. Pure human
butyrylcholinesterase hydrolyzes octanoyl ghrelin to desacyl ghrelin.
Gen. Comp. Endocrinol. 2015, 224, 61−68.
(16) Koryagina, N. L.; Savel’eva, E. I.; Karakashev, G. V.; Babakov, V.
N.; Dubrovskii, Y. A.; Ukolova, E. S.; Khlebnikova, N. S.; Murashko, E.
A.; Koneva, V. Y.; Ukolov, A. I.; Kopeikin, V. A.; Radilov, A. S.
Determination of protein adducts of organophosphorus nerve agents
in blood plasma. J. Anal. Chem. 2016, 71, 849−859.
(17) Du, D.; Wang, J.; Wang, L.; Lu, D.; Smith, J. N.; Timchalk, C.;
Lin, Y. Magnetic electrochemical sensing platform for biomonitoring
of exposure to organophosphorus pesticides and nerve agents based on
simultaneous measurement of total enzyme amount and enzyme
activity. Anal. Chem. 2011, 83, 3770−3777.
(18) Hrabovska, A.; Bernard, V.; Krejci, E. A novel system for the
efficient generation of antibodies following immunization of unique
knockout mouse strains. PLoS One 2010, 5, No. e12892.
(19) Mrvova, K.; Obzerova, L.; Girard, E.; Krejci, E.; Hrabovska, A.
Monoclonal antibodies to mouse butyrylcholinesterase. Chem.−Biol.
Interact. 2013, 203, 348−353.
(20) Peng, H.; Brimijoin, S.; Hrabovska, A.; Krejci, E.; Blake, T. A.;
Johnson, R. C.; Masson, P.; Lockridge, O. Monoclonal antibodies to
human butyrylcholinesterase reactive with butyrylcholinesterase in
animal plasma. Chem.−Biol. Interact. 2016, 243, 82−90.
(21) Masson, P.; Goasdoue, J.-L. Evidence that the conformational
stability of ‘aged’ organophosphate-inhibited cholinesterase is altered.
Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol. 1986, 869, 304−
313.
(22) Lockridge, O.; Adkins, S.; La Du, B. N. Location of disulfide
bonds within the sequence of human serum cholinesterase. J. Biol.
Chem. 1987, 262, 12945−12952.
(23) Li, H.; Schopfer, L. M.; Masson, P.; Lockridge, O. Lamellipodin
proline rich peptides associated with native plasma butyrylcholinester-
ase tetramers. Biochem. J. 2008, 411, 425−432.
(24) Biberoglu, K.; Schopfer, L. M.; Tacal, O.; Lockridge, O. The
proline-rich tetramerization peptides in equine serum butyrylcholines-
terase. FEBS J. 2012, 279, 3844−3858.
(25) Peng, H.; Schopfer, L. M.; Lockridge, O. Origin of polyproline-
rich peptides in human butyrylcholinesterase tetramers. Chem.−Biol.
Interact. 2016, 259, 63−69.
(26) Altamirano, C. V.; Lockridge, O. Conserved aromatic residues of
the C-terminus of human butyrylcholinesterase mediate the
association of tetramers. Biochemistry 1999, 38, 13414−13422.
(27) Weber, A.; Butterweck, H.; Mais-Paul, U.; Teschner, W.; Lei, L.;
Muchitsch, E.-M.; Kolarich, D.; Altmann, F.; Ehrlich, H. J.; Schwarz,
H. P. Biochemical, molecular and preclinical characterization of a
double-virus-reduced human butyrylcholinesterase preparation de-
signed for clinical use. Vox Sang. 2011, 100, 285−297.
ACS Omega Article
DOI: 10.1021/acsomega.6b00311
ACS Omega 2016, 1, 1182−1191
1191
